- Professor, Principle Investigator & Incharge of MEG Facility

Center of Excellence for Epilepsy, Neurology All India Institute of Medical Sciences
Neurosciences Centre, Room No. 705, 7th floor, Ansari Nagar, New Delhi 110029, India
Registration No: O11115 dated 26/08/1991 Orissa Medical council 2462 18/12/02 Medical Council of India
Email : manjari.tripathi1@gmail.com


About:
1. Chief author- Autoimmune encephalitis awarded best poster in DNACON-2013.
2. Awarded Anandi Bai Joshi award for Medicine in Third IRDS awards 2012.
3. Awarded the CHIEF OF THE ARMY STAFF AWARD for the best published article titled “Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy”. In the field of pathology and Allied Sciences on the 07th of February, 2012 at Armed forces Medical College, Pune.
4. Co and chief -Author in the awarded poster entitled “Triggering factors of seizures in people with epilepsy”. 13th Annual Conference of Indian Epilepsy Association and Indian Epilepsy Society ECON 2012”.
5. Awarded Fellow of Indian sleep disorders association April 2011.
6. Co-Author in the awarded poster entitled “Increased BDNF serum levels in Alzheimer’s disease (AD) and Mild cognitive impairment (MCI) patients in north Indian population”. Presented at the 2nd international Congress on Neurobiology, Psychopharmacology & treatment guidance. November 24th-27th 2011, Greece.
7. MNAM - ORATION- Allahabad- on pre-surgical evaluation of Intractable Epilepsy. Sept, 2008.
8. American Academy of Sleep Medicine (AASM), for International Fellowship May-July 2008
9. Chief author-Best paper in National Annual Epilepsy conference- Seizure clusters and where do they localize. ECON 2008.
10. Awarded, presented and spoke in the Penry Mini fellowship for epilepsy from March 11-17 th, 2006 (Wake Forest University, Winston Salem, NC).
11. Awarded, course of the NIH Introduction to the principles and practice of clinical research. Oct 05th to Feb 21 06.
12. Awarded the prestigious National Institute of Health (NIH-USA) Fellowship “UCLA,” 2005-06 in Epilepsy.


Funding:

1. An international pilot study of an internet based platform to run epilepsy trials. (EPINET) Universisty of Auckland, New Zealand.- Ongoing
2. “An International multi-centre, open parallel group, prospective, randomized, controlled trial to determine the effectiveness of treatment with continuous positive airways pressure (CPAP) in addition to standard care in reducing cardiovascular (CV) severe obstructive sleep apnea (OSA)” Principal Investigator/Save trial/ 5years.Monash University, Australia- Ongoing
3. A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to evaluate the Efficacy and Safety of PEGylated Interferon Beta-1a (BIIB017) in subjects with relapsing Multiple Sclerosis./PPD- Ongoing.
4. Registered in Global Audit of Treatment of Refractory Status Epilepticus.. UK-Italy Non Funded , Registry.
5. “Surgical treatment of intracerebral lobar Haemorrhage (STICH-II)” co-investigator in the ongoing INTERNATIONAL TRIAL on surgical treatment of intracerebral haematomas at AIIMS (completed- STICH-1, ongoing- STICH II). -Completed.
6. “International food trial for Stroke patients” on going at St John’s Medical Hospital at Bangalore and AIIMS New Delhi, centre coordinator:-AIIMS. – Completed.

 

Selected Publication:

1. Puneet Jain,1 Suvasini Sharma,2 and Tripathi M. Diagnosis and Management of Epileptic Encephalopathies in Children. Epilepsy Research and Treatment Volume 2013 (2013), Article ID 501981.
2. Munisamy M, Tripathi M, Behari M, Raghavan S, Jain DC, Ramanujam B, Arumugam K, Rajakannan T, Mallayasamy SR, Subbiah V. The Effect of Uridine Diphosphate Glucuronosyltransferase (UGT)1A6 Genetic Polymorphism on Valproic Acid Pharmacokinetics in Indian Patients with Epilepsy: A Pharmacogenetic Approach. Mol Diagn Ther. 2013 Jun 8. [Epub ahead of print].
3. Balamurugan E, Aggarwal M, Lamba A, Dang N, Tripathi M. Perceived trigger factors of seizures in persons with epilepsy. Seizure. 2013 Jun 24. doi:pii: S1059-1311(13)00177-5. 10.1016/j.seizure. 2013.05.018. [Epub ahead of print] PubMed PMID: 23806632.
4. Dalal K, Devarajan E, Pandey RM, Subbiah V, Tripathi M. Role of reflexology and antiepileptic drugs in managing intractable epilepsy - a randomized controlled trial. Forsch Complementmed. 2013; 20(2):104-11.
5. Banerjee J, Tripathi M, Chandra PS. Understanding complexities of synaptic transmission in medically intractable seizures. A paradigm of epilepsy research. Indian J Neurosurg 2013; 2:71-6.
6. Chandra SP, Bal CS, Jain S, Joshua SP, Gaikwad S, Garg A, Ansari A, Nehra A, Sarkar C, Tripathi M. Intra-Operative CoRegistration of MRI, PET and Electrocorticographic Data for Neocortical Lesional Epilepsies May Improve the Localization of the Epileptogenic Focus: A Pilot Study. World Neurosurg. 2013 Feb 21. pii: S1878-8750(13)00343-4. doi: 0.1016/j.wneu.2013.02.057. [Epub ahead of print].
7. Ankit Singhal, Tripathi M. Refractory status epilepticus. Neurology Asia 2013; 18 (1): 67 – 71.
8. Uttam AK, Joshi R, Dwivedi R, Prasad K, Padma MV, Bhatia R, Singh MB, Tripathi. M. Applicability of the new ILAE classification for epilepsies (2010) in persons with epilepsy at a tertiary care center in India. Epilepsia. 2013 54(4):751–756.
9. Ahsan Haroon, Tripathi M, R. Khanam, Divya Vohra. Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India.Annals of Indian Academy of Neurology. 2012; 15 (4): 289-93.
10. Yusuf U Khan, Omar Farooq, Tripathi M, Pervez Alam, Priyanka Sharma. Automated Non-Convulsive Seizure Detection: A Statistical Approach. Proceedings of International Conference on Communications & Electronics (ICCE) 2012: 227-30.